Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-20, Stock:JNJ, The news for the past five days is as follows:
2018-11-13: NEWS1: Understanding TransEnterix’s Operational Performance.NEWS2: How TransEnterix Has Been Performing in November.NEWS3: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for November 14, 2018.NEWS4: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for November 14, 2018.NEWS5: Health Care Sector Update for 11/13/2018: VKTX, CRON, VLRX, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Health Care Sector Update for 11/13/2018: VKTX, CRON, VLRX, JNJ, PFE, ABT, MRK, AMGN.NEWS7: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS8: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS9: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.
2018-11-14: NEWS1: AbbVie's HCV Drug Mavyret Succeeds in Label Expansion Study.NEWS2: AbbVie's HCV Drug Mavyret Succeeds in Label Expansion Study.NEWS3: Jury clears J&J of liability in California talc cancer case.NEWS4: AbbVie&apos;s HCV Drug Mavyret Succeeds in Label Expansion Study.NEWS5: Tandem Diabetes Care’s Operational Performance.NEWS6: Why Tandem Should Be on Your Stock Radar.NEWS7: Here’s how to easily reduce your investment risk just at the right time.NEWS8: Health Care Sector Update for 11/14/2018: CGC, CDNA, TLRY, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 11/14/2018: CGC, CDNA, TLRY, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Gauging Analysts’ Views on TransEnterix Stock.NEWS11: [$$] The Theranos tale exposes the dangers lurking in Silicon Valley.NEWS12: 3 Top Healthcare Stocks to Buy in November.NEWS13: 3 Top Healthcare Stocks to Buy in November.NEWS14: 3 Top Healthcare Stocks to Buy in November.
2018-11-15: NEWS1: XLV, SMH: Big ETF Inflows.NEWS2: XLV, SMH: Big ETF Inflows.NEWS3: Johnson & Johnson (JNJ) Up 3.4% Since Last Earnings Report: Can It Continue?.NEWS4: Johnson & Johnson (JNJ) Up 3.4% Since Last Earnings Report: Can It Continue?.NEWS5: Why Johnson & Johnson's Up 3% So Far in 2018.NEWS6: Why Johnson & Johnson's Up 3% So Far in 2018.NEWS7: MARKETS: Stocks could bounce here, but I'm selling the rally.NEWS8: Health Care Sector Update for 11/15/2018: QURE, EXEL, AVEO, JNJ, PFE, MRK, ABT, AMGN.NEWS9: Health Care Sector Update for 11/15/2018: QURE, EXEL, AVEO, JNJ, PFE, MRK, ABT, AMGN.NEWS10: Johnson & Johnson (JNJ) Up 3.4% Since Last Earnings Report: Can It Continue?.NEWS11: Why Johnson & Johnson&apos;s Up 3% So Far in 2018.NEWS12: Should You Be Pleased About The CEO Pay At Johnson & Johnson’s (NYSE:JNJ).NEWS13: Why Wall Street Is Still Bullish on Tandem Stock.
2018-11-16: NEWS1: Notable Friday Option Activity: JNJ, PDFS, ULTI.NEWS2: Notable Friday Option Activity: JNJ, PDFS, ULTI.NEWS3: How Bausch + Lomb/International Performed.NEWS4: Baxter International: Why Investors Are Interested.NEWS5: Analyzing Baxter International’s Operational Performance.NEWS6: Health Care Sector Update for 11/16/2018: HCM, VLRX, AZN, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 11/16/2018: HCM, VLRX, AZN, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for November 19, 2018.NEWS9: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for November 19, 2018.NEWS10: New jury fails to reach verdict in J&J South Carolina talc cancer trial.NEWS11: ACUVUE OASYS with Transitions Light Intelligent Technology Named Among TIME's 'Best Inventions of 2018'.
2018-11-19: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: Nasdaq Slides More Than 3% As These Dow Blue Chips Buck The Broad Sell-Off.NEWS3: Bulls Stampeded by Bears as FAANG Stocks Get Trampled.NEWS4: MorphoSys Says Janssen Initiates Phase 2 Study To Evaluate Guselkumab In HS.NEWS5: MorphoSys Says Janssen Initiates Phase 2 Study To Evaluate Guselkumab In HS.NEWS6: Pfizer, Other Pharma Stocks Should Continue to Do Well Amid Market Volatility.NEWS7: Pfizer's Oncology Offerings Present Opportunity for Long-Term Stock Growth.NEWS8: Notable ETF Inflow Detected - IWD, JPM, XOM, JNJ.NEWS9: Notable ETF Inflow Detected - IWD, JPM, XOM, JNJ.NEWS10: Dow Movers: AAPL, JNJ.NEWS11: Dow Movers: AAPL, JNJ.NEWS12: J&J Gets Positive CHMP Opinion for Prostate Cancer Treatment.NEWS13: J&J Gets Positive CHMP Opinion for Prostate Cancer Treatment.NEWS14: J&J Gets Positive CHMP Opinion for Prostate Cancer Treatment.NEWS15: Baxter International: Analysts Remain Bullish on the Stock.

Answer: Decrease